| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Leveljump Healthcare Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.024 |
| 52 Week High | CA$0.059 |
| 52 Week Low | CA$0.024 |
| Beta | 2.38 |
| 11 Month Change | 0% |
| 3 Month Change | -46.07% |
| 1 Year Change | -47.83% |
| 33 Year Change | -89.19% |
| 5 Year Change | n/a |
| Change since IPO | -87.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 75J | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 0.8% |
| 1Y | -47.8% | -0.9% | 2.0% |
Return vs Industry: 75J underperformed the German Healthcare industry which returned -0.9% over the past year.
Return vs Market: 75J underperformed the German Market which returned 2% over the past year.
Price Volatility
| 75J volatility | |
|---|---|
| 75J Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 75J's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 75J's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 27 | Mitch Geisler | www.leveljumphealthcare.com |
Leveljump Healthcare Corp., together with its subsidiaries, operates as a medical diagnostic imaging company. The company provides teleradiology services to its client hospitals. It also owns and operates imaging centers.
Leveljump Healthcare Corp. Fundamentals Summary
| 75J fundamental statistics | |
|---|---|
| Market cap | €3.29m |
| Earnings (TTM) | -€721.09k |
| Revenue (TTM) | €7.94m |
0.4x
P/S Ratio-4.6x
P/E RatioIs 75J overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 75J income statement (TTM) | |
|---|---|
| Revenue | CA$11.63m |
| Cost of Revenue | CA$8.32m |
| Gross Profit | CA$3.31m |
| Other Expenses | CA$4.37m |
| Earnings | -CA$1.06m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 28.49% |
| Net Profit Margin | -9.09% |
| Debt/Equity Ratio | 67.4% |
How did 75J perform over the long term?
See historical performance and comparison